Silicon Laboratories Inc. (NASDAQ:SLAB – Get Free Report) Director William G. Bock sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total transaction of $281,540.00. Following the completion of the transaction, the director now directly owns 32,115 shares of the company’s stock, valued at $4,520,828.55. This represents a 5.86 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Silicon Laboratories Stock Performance
Shares of NASDAQ:SLAB opened at $135.53 on Friday. The firm has a 50 day simple moving average of $123.32 and a 200-day simple moving average of $115.75. Silicon Laboratories Inc. has a twelve month low of $94.00 and a twelve month high of $154.91.
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last released its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.07. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.60%. The company had revenue of $166.00 million during the quarter, compared to the consensus estimate of $165.50 million. During the same quarter in the prior year, the firm posted $0.48 earnings per share. Silicon Laboratories’s revenue for the quarter was down 18.5% on a year-over-year basis. As a group, sell-side analysts predict that Silicon Laboratories Inc. will post -3.56 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
Several analysts have recently issued reports on the company. Stifel Nicolaus increased their price objective on Silicon Laboratories from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Monday, January 6th. StockNews.com upgraded Silicon Laboratories to a “sell” rating in a research note on Friday, November 8th. Morgan Stanley cut their target price on shares of Silicon Laboratories from $123.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. KeyCorp lifted their price target on shares of Silicon Laboratories from $115.00 to $160.00 and gave the stock an “overweight” rating in a research note on Wednesday. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Silicon Laboratories from $150.00 to $135.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 5th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, Silicon Laboratories presently has a consensus rating of “Hold” and a consensus target price of $133.56.
Read Our Latest Stock Report on SLAB
Silicon Laboratories Company Profile
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Featured Articles
- Five stocks we like better than Silicon Laboratories
- Trading Halts Explained
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Retail Stocks Investing, Explained
- 3 Buy-and-Hold Stocks for Long-Term Growth
- 3 Stocks to Consider Buying in October
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.